Abstract
Screening for colorectal cancer is commanding increasing attention. Other cancer screening programmes have been a part of public consciousness for some time, but, until recently, colorectal cancer screening has remained in the background. Fuelled by new research, market opportunities and increased recognition of individual risk, screening for colorectal cancer is becoming a recommended procedure, but controversy about how best to implement widespread screening remains.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]
BMC Public Health Open Access 22 December 2005
-
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study
BMC Cancer Open Access 19 January 2005
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Greenlee, R. T., Murray, T., Bolden, S. & Wingo, P. A. Cancer statistics, 2000. CA Cancer J. Clin. 50, 7–33 (2000).
Ries, L. A. et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer 88, 2398–2424 (2000).
Kramer, B. S., Gohagan, J. K. & Prorok, P. C. (eds) Cancer Screening: Theory and Practice (Marcel Dekker, New York, 1999).
Bond, J. H. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology. Ann. Intern. Med. 119, 836–843 (1993); erratum 120, 347 (1994).
Terdiman, J. P., Conrad, P. G. & Sleisenger, M. H. Genetic testing in hereditary colorectal cancer: indications and procedures. Am. J. Gastroenterol. 94, 2344–2356 (1999).
Schoen, R. E., Weissfeld, J. L. & Kuller, L. H. Sigmoidoscopy use among primary care physicians. Prev. Med. 24, 249–254 (1995).
Kelly, R. B. & Shank, J. C. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med. Care 30, 1029–1042 (1992).
Mandel, J. S., Church, T. R., Ederer, F. & Bond, J. H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl Cancer Inst. 91, 434–437 (1999).
Hardcastle, J. D. et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348, 1472–1477 (1996).
Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O. D. & Sondergaard, O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348, 1467–1471 (1996).
Lang, C. A. & Ransohoff, D. F. What can we conclude from the randomized controlled trials of fecal occult blood test screening? Eur. J. Gastroenterol. Hepatol. 10, 199–204 (1998).
Mandel, J. S. et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 343, 1603–1607 (2000).
Lieberman, D. A. Cost-effectiveness model for colon cancer screening. Gastroenterology 109, 1781–1790 (1995).
Newcomb, P. A. et al. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl Cancer Inst. 84, 1572–1575 (1992).
Selby, J. V., Friedman, G. D., Quesenberry, C. P. J. & Weiss, N. S. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326, 653–657 (1992).
Atkin, W. S., Cuzick, J., Northover, J. M. & Whynes, D. K. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341, 736–740 (1993).
Atkin, W. S. et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42, 560–565 (1998).
Cooper, G. S., Fortinsky, R. H., Hapke, R. & Landefeld, C. S. Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer 82, 1476–1481 (1998).
Schoen, R. E., Weissfeld, J. L., Bowen, N. J., Switzer, G. & Baum, A. Patient satisfaction with screening flexible sigmoidoscopy. Arch. Intern. Med. 160, 1790–1796 (2000).
Schoenfeld, P. et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology 117, 312–318 (1999).
Podolsky, D. K. Going the distance — the case for true colorectal-cancer screening. N. Engl. J. Med. 343, 207–208 (2000).
Schoen, R. E. Interrupting the adenoma–carcinoma sequence: screening for adenomas and cancer, now and in the future. Semin. Gastrointest. Dis. 11, 219–228 (2000).
Lieberman, D. A., Weiss, D. G. & the Veterans Affairs Cooperative Study Group. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 345, 555–560 (2001).
Schoen, R. E. et al. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology 115, 533–541 (1998).
Levin, T. R. et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. J. Am. Med. Assoc. 281, 1611–1617 (1999).
Rex, D. K., Johnson, D. A., Lieberman, D. A., Burt, R. W. & Sonnenberg, A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am. J. Gastroenterol. 95, 868–877 (2000).
Winawer, S. J. et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329, 1977–1981 (1993).
Citarda, F. et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48, 812–815 (2001).
Thiis-Evensen, E. et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand. J. Gastroenterol. 34, 414–420 (1999).
Lieberman, D. A. et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N. Engl. J. Med. 343, 162–168 (2000).
Imperiale, T. F. et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N. Engl. J. Med. 343, 169–174 (2000).
Cooper, G. S., Yuan, Z., Landefeld, C. S., Johanson, J. F. & Rimm, A. A. A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans. Cancer 75, 775–781 (1995).
Slattery, M. L. et al. A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer 78, 1666–1670 (1996).
Rex, D. K. et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112, 24–28 (1997).
Hixson, L. J., Fennerty, M. B., Sampliner, R. E. & Garewal, H. S. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest. Endosc. 37, 125–127 (1991).
Winawer, S. J. et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112, 594–642 (1997); errata 112, 1060 (1997) and 114, 625 (1998).
Cheong, Y., Farrow, R., Frank, C. S. & Stevenson, G. W. Utility of flexible sigmoidoscopy as an adjunct to double-contrast barium enema examination. Abdom. Imaging 23, 138–140 (1998).
Winawer, S. J. et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N. Engl. J. Med. 342, 1766–1772 (2000).
Fenlon, H. M. et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N. Engl. J. Med. 341, 1496–1503 (1999).
Rex, D. K., Vining, D. & Kopecky, K. K. An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy). Gastrointest. Endosc. 50, 309–313 (1999).
Hara, A. K. et al. Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology 205, 59–65 (1997).
Dachman, A. H. et al. CT colonography with three-dimensional problem solving for detection of colonic polyps. Am. J. Roentgenol. 171, 989–995 (1998).
Sonnenberg, A., Delco, F. & Bauerfeind, P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer? Am. J. Gastroenterol. 94, 2268–2274 (1999).
Sidransky, D. et al. Identification of RAS oncogene mutations in the stool of patients with curable colorectal tumors. Science 256, 102–105 (1992).
Minamoto, T. et al. Mutant KRAS in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer 75, 1520–1526 (1995).
Tobi, M., Luo, F. C. & Ronai, Z. Detection of KRAS mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J. Natl Cancer Inst. 86, 1007–1010 (1994).
Ahlquist, D. A. et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119, 1219–1227 (2000).
Ahlquist, D. A. Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed. Br. Med. J. 321, 254–255 (2000).
Khandker, R. K. et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int. J. Technol. Assess. Health Care 16, 799–810 (2000).
Frazier, A. L., Colditz, G. A., Fuchs, C. S. & Kuntz, K. M. Cost-effectiveness of screening for colorectal cancer in the general population. J. Am. Med. Assoc. 284, 1954–1961 (2000).
Loeve, F. et al. Endoscopic colorectal cancer screening: a cost-saving analysis. J. Natl Cancer Inst. 92, 557–563 (2000).
Sonnenberg, A., Delco, F. & Bauerfeind, P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer? Am. J. Gastroenterol. 94, 2268–2274 (1999).
Schoen, R. E. Families at risk for colorectal cancer: risk assessment and genetic testing. J. Clin. Gastroenterol. 31, 114–120 (2000).
Fuchs, C. S. et al. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med. 331, 1669–1674 (1994).
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Schoen, R. The case for population-based screening for colorectal cancer. Nat Rev Cancer 2, 65–70 (2002). https://doi.org/10.1038/nrc705
Issue Date:
DOI: https://doi.org/10.1038/nrc705
This article is cited by
-
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study
BMC Cancer (2005)
-
Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]
BMC Public Health (2005)
-
Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasia
Oncogene (2005)